Showing results (1-10 of 586) with videos related to
Sort By:
Pageof 59
Expert Review of Cardiovascular Therapy|June 12, 2024
Targeting obesity for therapeutic intervention in heart failure patientsRyosuke Sato, Stephan von HaehlingMed (New York, N.Y.)|March 9, 2024
One small STEP, one giant leap: Semaglutide in the obese phenotype of heart failure with preserved ejection fractionRyosuke Sato, Stephan von HaehlingMed (New York, N.Y.)|February 15, 2025
Reaching the SUMMIT? Benefits and potential risks associated with the use of tirzepatide in heart failure with preserved ejection fractionKristian Hellenkamp, Ryosuke Sato, Stephan von HaehlingDeutsche Medizinische Wochenschrift (1946)|March 9, 2026
[Targeted treatment of heart failure: iron deficiency and intravenous iron supplementation]Josefine Rudolph, Ryosuke Sato, Stephan von HaehlingEuropean Journal of Internal Medicine|November 9, 2024
Translating evidence into practice: Managing electrolyte imbalances and iron deficiency in heart failureRyosuke Sato, Michael J Koziolek, Stephan von HaehlingExpert Opinion on Drug Discovery|October 3, 2025
New models for cancer cachexia and their application to drug discoveryRyosuke Sato, Markus S Anker, Jochen Springer, et al.Expert Opinion on Pharmacotherapy|October 22, 2024
Pharmacological management of heart failure: a patient-centred approachGuglielmo Fibbi, Ryosuke Sato, Mirela Vatic, et al.Current Heart Failure Reports|October 19, 2022
Sarcopenia and Frailty in Heart Failure: Is There a Biomarker Signature?Ryosuke Sato, Mirela Vatic, Guilherme Wesley Peixoto da Fonseca, et al.Pharmacology Research & Perspectives|January 8, 2025
Mechanisms and pharmacotherapy of cancer cachexia-associated anorexiaRyosuke Sato, Guilherme Wesley Peixoto da Fonseca, Willian das Neves, et al.Innere Medizin (Heidelberg, Germany)|August 4, 2023
[Transthyretin amyloid cardiomyopathy]Frauke CzepluchPageof 59